Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:RBCA.A
NasdaqGS:RBCA.ABanks

A Look At Republic Bancorp (RBCA.A) Valuation After Mixed Q4 2025 Earnings Results

Republic Bancorp (RBCA.A) has come into focus after its Q4 2025 report, which combined higher revenue and net interest income with an adjusted EPS miss and increased net charge-offs, giving investors a mixed earnings picture. See our latest analysis for Republic Bancorp. The share price has moved to US$73.42, with a 1-day share price return of 1.12% and a 90-day share price return of 12.42%. The 1-year total shareholder return of 17.51% and 5-year total shareholder return of 104.74% point to...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead Pharmaceuticals (ARWR) Valuation After First Human Dosing Of Dual Gene RNAi Therapy For Mixed Hyperlipidemia

Arrowhead Pharmaceuticals (ARWR) has begun dosing participants in a Phase 1/2a trial of ARO DIMER PA, a dual gene targeting RNAi candidate for mixed hyperlipidemia related atherosclerotic cardiovascular disease. See our latest analysis for Arrowhead Pharmaceuticals. The ARO DIMER PA dosing update comes after a strong run in Arrowhead Pharmaceuticals' shares, with a 90 day share price return of 92.87% and a 1 year total shareholder return of 289.54%. Momentum has been building recently,...
KOSE:A005930
KOSE:A005930Tech

Is Samsung Electronics (KOSE:A005930) Still Attractive After A 201% One-Year Share Price Surge

If you are wondering whether Samsung Electronics is priced attractively right now, this article will walk you through what the current share price might be implying about its value. On a recent trading day, the stock closed at ₩150,400, with returns of 17.0% over the past month and 201.3% over the last year. Over the most recent 7 days, however, the share price declined by 1.1%. Recent coverage around Samsung often focuses on its role as a major global technology manufacturer and its...
CPSE:ALK B
CPSE:ALK BPharmaceuticals

Assessing ALK-Abelló (CPSE:ALK B) Valuation After CHMP Backing For Expanded EURneffy Use In Children

ALK-Abelló (CPSE:ALK B) is back in focus after regulators in Europe issued a positive opinion on extending EURneffy marketing authorisation to include a 1 mg nasal adrenaline spray for younger children. See our latest analysis for ALK-Abelló. The CHMP opinion appears to have been a fresh catalyst, with ALK-Abelló’s 1-day share price return of 2.12% standing out against a 30-day share price return decline of 6.44%. Its 1-year total shareholder return of 34.35% and 3-year total shareholder...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

A Look At Cooper Companies (COO) Valuation As Business Review And Activist Pressure Refocus Attention

Why Cooper Companies is back in focus Cooper Companies (COO) is back on investors’ radar after renewed analyst coverage at William Blair following activist investor pressure, alongside a company review of a potential separation of its CooperVision and CooperSurgical businesses. See our latest analysis for Cooper Companies. Cooper Companies’ share price has been relatively muted in the short term, with a 90 day share price return of 16.75% contrasting with a 1 year total shareholder return...
NYSE:SON
NYSE:SONPackaging

Sonoco Links Long Term Wind Deal With Leadership Shift And Execution Focus

Sonoco Products (NYSE:SON) has entered a 15 year Virtual Power Purchase Agreement with ENGIE North America to source renewable wind energy. The agreement is intended to support Sonoco's emissions reduction efforts and shift more of its operational energy use toward renewables. The company also announced the planned retirement of Chief Operating Officer Rodger Fuller, alongside an upcoming executive restructuring. For investors watching NYSE:SON, these updates arrive with the share price at...
NYSE:OUT
NYSE:OUTSpecialized REITs

Evaluating OUTFRONT Media (OUT) After A 47% One-Year Rally

If you are wondering whether OUTFRONT Media is still reasonably priced after its recent run, this article walks through what the current share price could imply about value. The stock last closed at US$25.23, with returns of 3.2% over 7 days, 6.4% over 30 days, 6.4% year to date, 47.5% over 1 year, 53.3% over 3 years, and 58.1% over 5 years. Those moves sit against a backdrop of ongoing interest in the company as an outdoor advertising REIT and continuing coverage in the financial press that...
NYSE:NUVB
NYSE:NUVBPharmaceuticals

Analyst Endorsements Of Ibtrozi Uptake Could Be A Game Changer For Nuvation Bio (NUVB)

In late January 2026, multiple research firms including Truist Financial and H.C. Wainwright reaffirmed positive views on Nuvation Bio after its Ibtrozi cancer franchise showed robust initial uptake despite seasonal headwinds. Analysts also highlighted the company’s mIDH1 glioma program, with key clinical readouts expected as early as 2026, adding another potential growth pillar to its oncology story. We’ll now look at how analyst enthusiasm around Ibtrozi’s early positioning as a preferred...
TSE:6758
TSE:6758Consumer Durables

Sony And TCL JV Talks Put Focus On Home Entertainment Valuation

Sony Group and TCL Electronics have signed a memorandum of understanding for a potential global joint venture covering Sony's TV and audio home entertainment business. The MOU includes an exclusivity agreement and contemplates brand licensing and operational integration across key consumer electronics markets. The arrangement would see the joint venture assume Sony's home entertainment operations, if finalized after further negotiations and approvals. For investors watching Sony Group,...
TSX:CLS
TSX:CLSElectronic

Celestica (TSX:CLS) Is Down 7.7% After Raising 2026 Outlook Amid AI Customer Shifts – Has The Bull Case Changed?

In late January 2026, Celestica reported past fourth-quarter 2025 and full-year 2025 results showing higher sales and earnings, raised its 2026 revenue outlook to US$17.00 billion, and issued first-quarter 2026 guidance projecting revenue between US$3.85 billion and US$4.15 billion. At the same time, reports that Google may shift some tensor processing unit assembly to other suppliers raised questions about Celestica’s future exposure to a key AI data center customer. We will examine how...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Reassessing Duolingo (DUOL) Valuation After A Steep Multi‑Month Share Price Pullback

Recent performance snapshot for Duolingo (DUOL) With no single headline event dominating attention, Duolingo (DUOL) has been drawing interest largely because of its recent share performance and fundamentals, prompting investors to reassess what the current price might already be reflecting. See our latest analysis for Duolingo. At a share price of $131.93, Duolingo’s recent 30 day share price return of a 25.24% decline and 90 day share price return of a 49.65% decline point to fading...
NYSE:SPOT
NYSE:SPOTEntertainment

Spotify’s Price Hike and Podcast Momentum Could Be A Game Changer For Spotify Technology (SPOT)

In recent months, Spotify has raised its US premium subscription price from US$11.99 to US$12.99 per month while reporting better‑than‑expected third‑quarter 2025 revenue, gross margin, and operating income amid growing engagement with video podcasts. The company’s push beyond music into podcasts and other high‑engagement formats, combined with analyst optimism about pricing power, is reshaping how investors view its long‑term role in global audio streaming. We’ll examine how Spotify’s...
TSX:WSP
TSX:WSPConstruction

U.S. Rare Earth Mandate Might Change The Case For Investing In WSP Global (TSX:WSP)

USA Rare Earth Inc. previously announced it had selected Fluor Corp. and WSP Global Inc. as Engineering, Procurement and Construction Management partners to advance the Definitive Feasibility Study for the Round Top Rare Earth Project in Sierra Blanca, Texas. This mandate highlights WSP’s role in enabling a Western-aligned rare earths supply chain that supports defense, electrification, renewable energy and advanced manufacturing industries. Next, we’ll explore how participating in a major...
NYSE:WY
NYSE:WYSpecialized REITs

Weyerhaeuser Maps 2030 EBITDA Goal With Dividend Lift And Buybacks

Weyerhaeuser (NYSE:WY) has announced an increase to its base dividend alongside a new share repurchase program. The company plans significant divestitures of non core timberlands as part of a portfolio reshaping effort. Management has outlined a long term growth strategy targeting higher EBITDA by 2030. For investors watching NYSE:WY, these decisions come as the stock trades around $25.84, with a 30 day return of 8.6% and a 1 year return showing a decline of 13.2%. Over 3 and 5 years, the...
TSE:5444
TSE:5444Metals and Mining

Yamato Kogyo (TSE:5444) Valuation Check After Securities Sale And Expected Extraordinary Income

Yamato Kogyo (TSE:5444) has reported that its board resolved on February 2, 2026 to sell part of its investment securities and expects to book extraordinary income, a move that feeds directly into headline financials. See our latest analysis for Yamato Kogyo. The decision to sell part of its investment securities and recognize extraordinary income comes at a time when Yamato Kogyo’s share price, at ¥11,400, follows a 1 month share price return of 6.64% and a 3 month share price return of...
XTRA:BAS
XTRA:BASChemicals

Will BASF’s (XTRA:BAS) Lower 2025 EBIT but Stronger Net Income Guidance Change Its Narrative?

In January 2026, BASF issued guidance for 2025, forecasting sales of €59.7 billion and EBIT of €1.6 billion, both below 2024 levels when excluding discontinued Coatings operations. Despite the softer sales and EBIT outlook, BASF expects 2025 net income of €1.6 billion, comfortably above both analyst consensus and the prior year. Next, we’ll assess how BASF’s lower EBIT but stronger net income guidance shapes the company’s investment narrative for the year ahead. The end of cancer? These 29...
NasdaqGM:USAR
NasdaqGM:USARMetals and Mining

Is It Too Late To Reassess USA Rare Earth (USAR) After Its Sharp Share Price Rally?

This article is designed to help you think about whether USA Rare Earth is starting to look like good value after a strong run, or whether the current price already reflects the story. USA Rare Earth shares closed at US$22.11, with a 30 day return of 56.3%, a 7 day return showing a 16.1% decline, and a 1 year return of 74.1%, indicating that the stock has seen sharp moves recently. Recent attention on USA Rare Earth has focused on its role in the US rare earth supply chain and the broader...
NYSE:ATR
NYSE:ATRPackaging

A Look At AptarGroup (ATR) Valuation As Analyst Revisions Turn More Cautious On Earnings

Recent analyst revisions have turned more cautious on AptarGroup (ATR). Consensus EPS expectations have moved lower despite higher projected revenues, putting margins and costs at the center of the earnings debate. See our latest analysis for AptarGroup. AptarGroup shares recently traded at $124.83, with a 90 day share price return of 9.33% contrasting with a 1 year total shareholder return decline of 18.98%. This suggests recent momentum has improved even as longer term returns remain under...
NasdaqGS:SFD
NasdaqGS:SFDFood

A Look At Smithfield Foods (SFD) Valuation After Recent Share Price Momentum

Smithfield Foods (SFD) is back on investor screens after recent share price moves, with the stock returning 9.3% over the past month and 16.0% over the past 3 months. See our latest analysis for Smithfield Foods. That recent 9.3% 1 month share price return sits alongside a 9.9% 3 month share price return and a 16.0% 1 year total shareholder return. Together, these figures point to momentum building rather than fading around the current US$24.20 level. If Smithfield Foods has caught your eye,...
NasdaqGM:APPF
NasdaqGM:APPFSoftware

Why AppFolio (APPF) Is Down 10.9% After Mixed 2025 Results and New 2026 Revenue Guidance

In late January 2026, AppFolio reported its fourth-quarter and full-year 2025 results, with revenue rising to US$248.19 million for Q4 and US$950.82 million for the year, alongside lower net income and earnings per share versus 2024. The company also issued 2026 guidance calling for full-year revenue of US$1.10 billion to US$1.12 billion, highlighting expectations tied to its AI-native performance platform and premium tier adoption. With the company now guiding 2026 revenue to US$1.10–1.12...
NYSE:S
NYSE:SSoftware

How Investors Are Reacting To SentinelOne (S) CFO Shift Amid Growth Concerns And Insider Buying

SentinelOne recently confirmed that Barry Padgett, previously its Chief Growth Officer, became interim Chief Financial Officer and principal financial officer on January 16, 2026, following the mid-January departure of former CFO Barbara Larson. At the same time, investors are weighing insider share purchases and new partnerships against concerns raised by analysts about SentinelOne’s future revenue trajectory. We’ll now examine how the CFO transition, alongside analyst concerns about future...
ENXTPA:SAN
ENXTPA:SANPharmaceuticals

Is Sanofi (ENXTPA:SAN) Offering An Opportunity After A 19.6% One Year Share Price Decline?

If you are wondering whether Sanofi shares offer good value right now, the key is to look closely at what the current price is actually baking in about the company. The stock closed at €80.45 recently, with returns of 0.7% over the past week, a 2.3% decline over the last month, and a 19.6% decline over the last year, while the 3 year and 5 year returns sit at 6.9% and 21.3% respectively. Recent attention on Sanofi has been shaped by broader sector news and company specific updates around its...